Build Ventures
Build Ventures
Type of Funding
Venture Capital
Max Funding
N/A
Region
Atlantic Canada
Application Difficuty
Fairly simple
Processing Time
Slow (A few months)
Province
New Brunswick
Nova Scotia
Prince Edward Island
Nova Scotia
Prince Edward Island
Industry
Computer system/Software and data processing.
Funding Goals
Start-up Funding.
Demographic
N/A
Incorporated
No
Contact
rob@buildventures.ca
Apply For A Loan
Business location – Canada
Monthly Revenue – $10K +
Time in Business – 6 months +
Funds in 24 hours
$10,000 to $800,000
Details
Build Ventures is based in Halifax, Nova Scotia and is focused on early stage technology companies across the Atlantic region.
Their first fund closed in early 2013 and we currently have $65M under management.
They are looking to work with passionate founders who are committed to building great companies.
Eligibility
Early stage companies
Similar funding programs
Venture Capital
iGan Partners is a Canadian healthcare technology venture capital firm.
They invest in and help management teams build disruptive and scalable businesses.
They have a track-record in Medical Devices, Health IT and SaaS and are open to related opportunities where we can leverage our expertise and networks. They provide companies with smart-capital, active support and access to a network of industry partners and sector specific co-investors to help them grow and succeed.
Max Funding N/A
iGan Partners
Venture Capital
Chrysalix is a global venture capital fund with a long history commercializing step-change innovation for resource intensive industries.
They invest in intelligent systems, energy technology and resource productivity solutions to deliver outsized financial returns and environmental sustainability.
Chrysalix is an award-winning technology-focused venture capital company with a long history of building and commercializing innovations for Resource Intensive Industries.
Max Funding N/A
Chrysalix
Venture Capital
Built on a foundation that leverages over 20 years of experience as one of North America's leading healthcare and life science venture capital investors, Lumira Ventures is the successor business to MDS Capital.
Their team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.
Max Funding N/A
Lumira Ventures